BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 607047)

  • 1. [Specific immune reactivity in patients with malignant melanoma (author's transl)].
    Poljak-Blazi M; Montani D; Ferle-Vidović A; Boranić M
    Lijec Vjesn; 1977 Dec; 99(12):735-8. PubMed ID: 607047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological monitoring in patients with malignant melanoma (author's transl)].
    Uhrík J; Jurga L; Hejj F; Cichý A; Dubivská M; Gumanová Z
    Cesk Dermatol; 1980; 55(6):361-67. PubMed ID: 7460038
    [No Abstract]   [Full Text] [Related]  

  • 3. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tumor immunoreactivity in patients with malignant melanoma.
    Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH
    Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary results of immuno-surgical treatment of primary melanoma (author's transl)].
    Vanwicjk R; Rustin P; Malek-Mansour S; Castermans-Elias S; Castermans A
    Acta Chir Belg; 1975 Jul; 74(4):430-40. PubMed ID: 1146463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unspecific immunological investigations in patients with malignant melanoma (author's transl)].
    Knopf B; Wätzig V
    Dermatol Monatsschr; 1982 Jan; 168(1):24-33. PubMed ID: 7044849
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic reactions in malignant melanoma of the skin in man].
    Veresova OV; Korosteleva TA
    Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
    [No Abstract]   [Full Text] [Related]  

  • 8. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
    Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
    Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunology of malignant melanomas].
    Schieferstein G
    Fortschr Med; 1976 May; 94(14):833-7. PubMed ID: 1270047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant melanoma in husband and wife (author's transl)].
    Schlaeger M; Tritsch H
    Dtsch Med Wochenschr; 1978 Jun; 103(23):968, 975-7. PubMed ID: 648396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative examinations of the effect of general and local anesthesia upon the T-lymphocytes in melanoma operations (author's transl)].
    Seebacher C; Bässler E
    Arch Geschwulstforsch; 1981; 51(2):179-86. PubMed ID: 6973960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune status of patients with malignant melanoma during combined therapy including local ultra-high frequency hyperthermia].
    Risina DIa; Zhakov IG; Fradkin SZ; Zhabrid EA
    Vopr Onkol; 1989; 35(12):1437-40. PubMed ID: 2532801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Humoral antitumor cytotoxins in patients with melanoma of the skin].
    Korosteleva TA; Veresova OV; Khachaturian LM
    Vopr Onkol; 1975; 21(5):61-3. PubMed ID: 1210146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
    Rangel DM; Golub SH; Morton DL
    Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunology of malignant melanoma].
    Bourgoin JJ
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):789-807. PubMed ID: 4559237
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immunity against malignant melanoma in monozygous twins.
    Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
    Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
    Jehn UW; Nathanson L; Schwartz RS; Skinner M
    N Engl J Med; 1970 Aug; 283(7):329-33. PubMed ID: 4193645
    [No Abstract]   [Full Text] [Related]  

  • 19. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological conditions in patients with malignant melanoma of the skin].
    Kristensen E
    Ugeskr Laeger; 1976 Feb; 138(8):463-8. PubMed ID: 1258214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.